GL1X · GenesisL1 explorer

MolNFT v1 · #148901 · protein

Crystal structure of N2C/D282C stabilized opsin bound to RS09

6FK9 · Rhodopsin: “Crystal structure of N2C/D282C stabilized opsin bound to RS09”. X-ray diffraction, 6 ligands (ACE, PLM, DNK), 4 pockets (best druggability 0.83). MolNFT v1 #148901 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6FK9
Type
protein
Length
326 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rhodopsin
UniProt
P02699
Ligands
ACE, PLM, DNK, NAG, MAN, BMA
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 69% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARhodopsinprotein32669% helix, 4% strandP02699

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • PLM · Palmitic acid · ligand · chains A
  • DNK · (2~{S})-3-methyl-2-phenyl-1-spiro[1,3-benzodioxole-2, 4'-piperidine]-1'-yl-butan-1-one · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies
  • BMA · beta-D-mannopyranose · sugar
  • BOG · octyl beta-D-glucopyranoside · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17220.830.8663BOG, DNK
21150.570.8423BOG
32120.500.7524empty
4660.330.7512empty

Modifications

Observed in the structure: 3 covalent, 2 disulfide, 1 glycan, 1 lipid (additive adduct, disulfide, covalent ligand, N-glycosylation, palmitoylation).

Compared structures

  • 6FK9 · Crystal structure of N2C/D282C stabilized opsin bound to RS09 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.